Quantitative Approaches to Assess Key Carcinogenic Events of Genotoxic Carcinogens |
Fukushima, Shoji
(Association for Promotion of Research on Risk Assessment)
Gi, Min (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) Fujioka, Masaki (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) Kakehashi, Anna (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) Wanibuchi, Hideki (Department of Molecular Pathology, Osaka City University Graduate School of Medicine) Matsumoto, Michiharu (Japan Bioassay Research Center) |
1 | Murai, T., Mori, S., Kang, J.S., Morimura, K., Wanibuchi, H., Totsuka, Y. and Fukushima, S. (2008) Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats. Toxicol. Pathol., 36, 472-477. DOI |
2 | MacGregor, J.T., Frotschl, R., White, P.A., Crump, K.S., Eastmond, D.A., Fukushima, S., Guerard, M., Hayashi, M., Soeteman-Hernandez, L.G., Kasamatsu, T., Levy, D.D., Morita, T., Muller, L., Schoeny, R., Schuler, M.J., Thybaud, V. and Johnson, G.E. (2015) IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). Mutat. Res. Genet. Toxicol. Environ. Mutagen., 783, 55-65. DOI |
3 | MacGregor, J.T., Frotschl, R., White, P.A., Crump, K.S., Eastmond, D.A., Fukushima, S., Guerard, M., Hayashi, M., Soeteman-Hernandez, L.G., Johnson, G.E., Kasamatsu, T., Levy, D.D., Morita, T., Muller, L., Schoeny, R., Schuler, M.J. and Thybaud, V. (2015) IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of pointof-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 783, 66-78. DOI |
4 | Kang, J.S., Wanibuchi, H., Morimura, K., Totsuka, Y., Yoshimura, I. and Fukushima, S. (2006) Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in rats. Cancer Sci., 97, 453-458. DOI |
5 | Peto, R., Gray, R., Brantom, P. and Grasso, P. (1991) Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res., 51, 6415-6451. |
6 | Ito, N., Tamano, S. and Shirai, T. (2003) A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci., 94, 3-8. DOI |
7 | Kato, T., Ohgaki, H., Hasegawa, H., Sato, S., Takayama, S. and Sugimura, T. (1988) Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis, 9, 71-73. DOI |
8 | Kushida, H., Wakabayashi, K., Sato, H., Katami, M., Kurosaka, R. and Nagao, M. (1994) Dose-response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett., 83, 31-35. DOI |
9 | IARC (1993) IARC monographs on the evaluation of carcinogenic risks to humans: Some nuturally occurring substances: food items and constituents, heterocylic aromatic amines and mycotoxins. MeIQx (2-amino-3,8-dimethylimidazo( 4,5-f)quinoxaline), World Health Organization, International Agency for Research on Cancer, Lyon. |
10 | Fukushima, S., Wanibuchi, H., Morimura, K., Wei, M., Nakae, D., Konishi, Y., Tsuda, H., Uehara, N., Imaida, K., Shirai, T., Tatematsu, M., Tsukamoto, T., Hirose, M., Furukawa, F., Wakabayashi, K. and Totsuka, Y. (2002) Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine. Jpn J. Cancer Res., 93, 1076-1082. DOI |
11 | Hoshi, M., Morimura, K., Wanibuchi, H., Wei, M., Okochi, E., Ushijima, T., Takaoka, K. and Fukushima, S. (2004) Noobserved effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. Toxicol. Sci., 81, 273-279. DOI |
12 | Farmer, J.H., Kodell, R.L., Greenman, D.L. and Shaw, G.W. (1980) Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J. Environ. Pathol. Toxicol., 3, 55-68. |
13 | Fukushima, S., Wanibuchi, H., Morimura, K., Wei, M., Nakae, D., Konishi, Y., Tsuda, H., Takasuka, N., Imaida, K., Shirai, T., Tatematsu, M., Tsukamoto, T., Hirose, M. and Furukawa, F. (2003) Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Lett., 191, 35-40. DOI |
14 | Wei, M., Hori, T.A., Ichihara, T., Wanibuchi, H., Morimura, K., Kang, J.S., Puatanachokchai, R. and Fukushima, S. (2006) Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats. Cancer Lett., 231, 304-308. DOI |
15 | Ohgaki, H., Hasegawa, H., Kato, T., Suenaga, M., Ubukata, M., Sato, S., Takayama, S. and Sugimura, T. (1986) Carcinogenicity in mice and rats of heterocyclic amines in cooked foods. Environ. Health Perspect., 67, 129-134. DOI |
16 | IARC (1993) IARC monographs on the evaluation of carcinogenic risks to humans: Some nuturally occurring substances: food items and constituents, heterocylic aromatic amines and mycotoxins. IQ (2-amino-3-methylimidazo(4,5-f)quinoline), World Health Organization, International Agency for Research on Cancer, Lyon. |
17 | Wei, M., Wanibuchi, H., Nakae, D., Tsuda, H., Takahashi, S., Hirose, M., Totsuka, Y., Tatematsu, M. and Fukushima, S. (2011) Low-dose carcinogenicity of 2-amino-3-methylimidazo[ 4,5-f]quinoline in rats: Evidence for the existence of no-effect levels and a mechanism involving p21(Cip/WAF1). Cancer Sci., 102, 88-94. DOI |
18 | Fukushima, S., Gi, M., Kakehashi, A. and Wanibuchi, H. (2016) Qualitative and quantitative assessment on low-dose carcinogenicity of genotoxic hepatocarcinogens: Dose-response for key events in rat hepatocarcinogenesis in Thresholds of Genotoxic Carcinogen (Nohmi, T. and Fukushima, S. Eds.). Academic Press, pp. 1-17. |
![]() |